Literature DB >> 13679821

Identification of IgE-binding epitopes of the major peach allergen Pru p 3.

Gloria García-Casado1, Luis F Pacios, Araceli Díaz-Perales, Rosa Sánchez-Monge, Manuel Lombardero, Francisco J García-Selles, Florentino Polo, Domingo Barber, Gabriel Salcedo.   

Abstract

BACKGROUND: Lipid transfer proteins (LTPs) are clinically relevant plant food panallergens and have been proposed as ideal tools to study true food allergy. Pru p 3, the major peach allergen in the Mediterranean area, is among the best-characterized allergenic members of the LTP family. Its diagnostic value for Rosaceae fruit allergy has been demonstrated both in vivo and in vitro.
OBJECTIVE: We sought to locate major IgE-binding epitopes of Pru p 3.
METHODS: A serum pool and individual sera from patients with peach allergy and positive skin prick test results to Pru p 3 were used. Three-dimensional modeling was achieved by using experimentally available structures of Pru p 3 homologues as templates. Theoretical prediction of potential IgE-binding regions was performed by selecting specific residues on the molecular surface displaying prominent electrostatic potential features. Point mutants of Pru p 3 were constructed by standard polymerase chain reaction procedures with the appropriate primers. Mutants were expressed in P pastoris by means of the pPIC 9 vector and purified from the corresponding supernatants by gel-filtration chromatography followed by RP-HPLC. IgE binding by Pru p 3 mutants was tested by immunodetection and quantified by ELISA and ELISA inhibition assays. Synthetic peptides (10 mer; 5 amino acids overlapping) covering the full Pru p 3 sequence were used to detect IgE epitopes by (125)I-anti-IgE immunodetection.
RESULTS: Pru p 3 showed a 3-dimensional structure comprising 4 alpha-helixes and a nonstructured C-terminal coil (residues 73 to 91). Regions around amino acids in positions 23 to 36, 39 to 44, and 80 to 91, particularly residues R39, T40, and R44, K80 and K91, were predicted as potential antibody recognition sites according to their relevant surface and electrostatic properties. Point mutants K80A and K91A were found to have an IgE-binding capacity similar to that of recombinant Pru p 3, but the triple mutant R39A/T40A/R44A showed a substantial decrease (approximately 5 times) of IgE binding. IgE immunodetection of synthetic peptides led to the identification of Pru p 3 sequence regions 11 to 25, 31 to 45, and 71 to 80 as major IgE epitopes.
CONCLUSIONS: Main IgE-binding regions of the Pru p 3 amino acid sequence were identified. The three major ones comprised the end of an alpha-helix and some residues of the following interhelix loop. These data can help to search for Pru p 3 hypoallergenic forms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679821     DOI: 10.1016/s0091-6749(03)01605-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  31 in total

1.  Structure and functional features of olive pollen pectin methylesterase using homology modeling and molecular docking methods.

Authors:  Jose C Jimenez-Lopez; Simeon O Kotchoni; María I Rodríguez-García; Juan D Alché
Journal:  J Mol Model       Date:  2012-06-22       Impact factor: 1.810

2.  Hydrogen/deuterium exchange memory NMR reveals structural epitopes involved in IgE cross-reactivity of allergenic lipid transfer proteins.

Authors:  Martina Di Muzio; Sabrina Wildner; Sara Huber; Michael Hauser; Eva Vejvar; Werner Auzinger; Christof Regl; Josef Laimer; Danila Zennaro; Nicole Wopfer; Christian G Huber; Ronald van Ree; Adriano Mari; Peter Lackner; Fatima Ferreira; Mario Schubert; Gabriele Gadermaier
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

Review 3.  Relevant B cell epitopes in allergic disease.

Authors:  Anna Pomés
Journal:  Int Arch Allergy Immunol       Date:  2009-11-26       Impact factor: 2.749

4.  Cross-React: a new structural bioinformatics method for predicting allergen cross-reactivity.

Authors:  Surendra S Negi; Werner Braun
Journal:  Bioinformatics       Date:  2017-04-01       Impact factor: 6.937

5.  Conformational IgE epitopes of peanut allergens Ara h 2 and Ara h 6.

Authors:  Xueni Chen; Surendra S Negi; Sumei Liao; Valerie Gao; Werner Braun; Stephen C Dreskin
Journal:  Clin Exp Allergy       Date:  2016-06-27       Impact factor: 5.018

6.  Hydrogen/deuterium exchange memory NMR reveals structural epitopes involved in IgE cross-reactivity of allergenic lipid transfer proteins.

Authors:  Martina Di Muzio; Sabrina Wildner; Sara Huber; Michael Hauser; Eva Vejvar; Werner Auzinger; Christof Regl; Josef Laimer; Danila Zennaro; Nicole Wopfner; Christian G Huber; Ronald van Ree; Adriano Mari; Peter Lackner; Fatima Ferreira; Mario Schubert; Gabriele Gadermaier
Journal:  J Biol Chem       Date:  2020-10-09       Impact factor: 5.157

Review 7.  The role of lipid transfer proteins in allergic diseases.

Authors:  Matthias Egger; Michael Hauser; Adriano Mari; Fatima Ferreira; Gabriele Gadermaier
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

8.  Structural functionality, catalytic mechanism modeling and molecular allergenicity of phenylcoumaran benzylic ether reductase, an olive pollen (Ole e 12) allergen.

Authors:  Jose C Jimenez-Lopez; Simeon O Kotchoni; Maria C Hernandez-Soriano; Emma W Gachomo; Juan D Alché
Journal:  J Comput Aided Mol Des       Date:  2013-10-24       Impact factor: 3.686

9.  Linkage map positions and allelic diversity of two Mal d 3 (non-specific lipid transfer protein) genes in the cultivated apple (Malus domestica).

Authors:  Z S Gao; W E van de Weg; J G Schaart; I M van der Meer; L Kodde; M Laimer; H Breiteneder; K Hoffmann-Sommergruber; L J W J Gilissen
Journal:  Theor Appl Genet       Date:  2005-01-13       Impact factor: 5.699

10.  Epitope Mapping of Allergenic Lipid Transfer Proteins.

Authors:  Clara San Bartolomé; Carmen Oeo-Santos; Pablo San Segundo-Acosta; Rosa Muñoz-Cano; Javier Martínez-Botas; Joan Bartra; Mariona Pascal
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.